Sort
23,748 grants matching “melanoma”
Oncogene c-Myc-dependent pathways in cutaneous melanoma
$318,635Mikhail Nikiforov · Roswell Park Cancer Institute Corp · R01 · FY2008 · CA
HEF1 Coordination of Cell Cycle, Migration, and Invasion in Cancer
$318,618Erica A Golemis · Research Inst Of Fox Chase Can Ctr · R01 · FY2011 · CA
Rational Sequencing of PD-1 and CTLA-4 Antibodies in Metastatic Melanoma
$318,600Jeffrey S Weber · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2014 · CA
Cellular Pharmacology of Rapamycin
$318,589Gary G Chiang · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2007 · CA
Personalized melanoma chemoprevention
$318,586Douglas Grossman · University Of Utah · R01 · FY2015 · CA
Personalized melanoma chemoprevention
$318,586Douglas Grossman · University Of Utah · R01 · FY2016 · CA
P2 - CYCLIN B1 IN IMMUNOTHERAPY, DIAGNOSIS, AND PROGNOSIS OF LUNG CANCER
$318,569Olivera J Finn · University Of Pittsburgh At Pittsburgh · P50 · FY2009 · CA
P2 - CYCLIN B1 IN IMMUNOTHERAPY, DIAGNOSIS, AND PROGNOSIS OF LUNG CANCER
$318,563Olivera J Finn · University Of Pittsburgh At Pittsburgh · P50 · FY2010 · CA
Enhancing Immunological Memory Using Aptamertargeted siRNA Delivery to T Cells
$318,513Eli Gilboa · University Of Miami School Of Medicine · R01 · FY2017 · CA
Enhancing Immunological Memory Using Aptamertargeted siRNA Delivery to T Cells
$318,513Eli Gilboa · University Of Miami School Of Medicine · R01 · FY2016 · CA
Rational targeting of protein translation of cancer treatments
$318,513France Carrier · University Of Maryland Baltimore · R01 · FY2016 · CA
Enhancing Immunological Memory Using Aptamertargeted siRNA Delivery to T Cells
$318,513Eli Gilboa · University Of Miami School Of Medicine · R01 · FY2015 · CA
Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks.
$318,513Patricia Yotnda · Baylor College Of Medicine · R01 · FY2010 · CA
Targeting the Pim 1 Protein Kinase to Overcome Resistance to AKT Inhibitors
$318,513Andrew S Kraft · University Of Arizona · R01 · FY2016 · CA
Rational targeting of protein translation of cancer treatments
$318,513France Carrier · University Of Maryland Baltimore · R01 · FY2017 · CA
Targeting the Pim 1 Protein Kinase to Overcome Resistance to AKT Inhibitors
$318,513Andrew S Kraft · University Of Arizona · R01 · FY2017 · CA
Enhancing Immunological Memory Using Aptamertargeted siRNA Delivery to T Cells
$318,513Eli Gilboa · University Of Miami School Of Medicine · R01 · FY2014 · CA
Rational targeting of protein translation of cancer treatments
$318,513France Carrier · University Of Maryland Baltimore · R01 · FY2013 · CA
Rational targeting of protein translation of cancer treatments
$318,513France Carrier · University Of Maryland Baltimore · R01 · FY2015 · CA
Impact of IKKB and AurK Inhibitors on Host Immunity and Melanoma
$318,507Ann Richmond · Vanderbilt University · R01 · FY2014 · CA
US Detection of Sentinel Lymph Nodes in Melanoma
$318,489Thomas Jefferson University · R01 · FY2005 · CA
Development of an HTS assay for ySas2/hMOF histone acetyltransferase inhibitors
$318,472Ronen Marmorstein · Wistar Institute · R01 · FY2011 · GM
Development of an HTS assay for ySas2/hMOF histone acetyltransferase inhibitors
$318,472Ronen Marmorstein · Wistar Institute · R01 · FY2012 · GM
Role of a novel Notch1 target gene in skin carcinogenesis
$318,418Anna Mandinova · Massachusetts General Hospital · R01 · FY2010 · CA
Generation of Anti-Melanoma T Cells Derived from Human Embryonic Stem Cells
$318,349Jerome A. Zack · California Institute Of Technology · P01 · FY2010 · CA